
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1051 | 1051 | 1020 | 1039 | 1575 | 1532 |
Fund Return | 5.07% | 5.07% | 1.99% | 1.27% | 9.51% | 4.36% |
Place in category | 73 | 73 | 176 | 246 | 146 | 163 |
% in Category | 25 | 25 | 50 | 68 | 49 | 79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Laudus US Large Cap Growth | 1.92B | -9.82 | 8.09 | 13.01 | ||
Laudus Mondrian Emerging Markets In | 18.52M | 5.60 | 1.09 | 1.55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Europacific Growth R | 57.91B | 2.62 | 3.28 | 5.33 | ||
Vanguard International Growth Adm | 37.78B | 1.42 | 1.83 | 8.25 | ||
American Funds Europacific Growth F | 18.27B | 2.60 | 3.16 | 5.21 | ||
American Funds Europacific Growth A | 17.79B | 2.53 | 2.89 | 4.95 | ||
WCM Focused International Growth I | 16.93B | 5.15 | 4.08 | 9.21 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Schwab Emerging Markets Equity | US8085247067 | 2.61 | 26.58 | +0.83% | |
Msci Eafe Mar25 Ifus 20250321 | - | 2.30 | - | - | |
Novo Nordisk B | DK0062498333 | 1.28 | 435.4 | -0.11% | |
Novartis | CH0012005267 | 1.09 | 89.06 | +0.36% | |
Roche Holding Participation | CH0012032048 | 0.95 | 249.90 | -0.72% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Strong Sell |
Technical Indicators | Neutral | Neutral | Neutral |
Summary | Neutral | Neutral | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review